PuraPharm Corporation Limited (1498.HK) HKSE
0.30
+0(+0.00%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.30
+0(+0.00%)
Currency In HKD
| Market Cap | 148.67M |
| Enterprise Value | 478.63M |
| P/E Ratio | -3.77 |
| PEG Ratio | -1.51 |
| Price/Sales Ratio | 0.37 |
| Price/Book Ratio | 1.02 |
| Enterprise/Revenue | 1.36 |
| Enterprise/EBITDA | 73.14 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.1 |
| Operating Margin | -0.09 |
| Return On Assets | -0.05 |
| Return On Equity | -0.3 |
| Revenue | 336.11M |
| Revenue/Share | 0.76 |
| Gross Profit | 180.16M |
| EBITDA | 6.23M |
| Net Income | -35.22M |
| Diluted EPS | -0.08 |
| Total Cash | 21.18M |
| Total Cash/Share | 0.05 |
| Total Debt | 351.14M |
| Total Debt/Equity | 2.69 |
| Current Ratio | 0.47 |
| Book Value Per Share | 0.3 |
| 52-Week Change | -41.18 |
| 52-Week High | 0.52 |
| 52-Week Low | 0.28 |
| Moving Average 50 Days | 0.3 |
| Moving Average 200 Days | 0.36 |
| Average Volume | 432,979 |
| Shares Outstanding | 418.57M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 18:17 |
| Last Split Date | January 29, 2020 |